Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference28 articles.
1. HOW STRONG IS THE CASE FOR INTENSIVE CANCER CHEMOTHERAPY?
2. Dose: A critical factor in cancer chemotherapy
3. The importance of dose intensity in chemotherapy of metastatic breast cancer.
4. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1966.
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: A systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology;2024-09-08
2. Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy;Veterinary and Comparative Oncology;2023-03-27
3. Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer;Anticancer Research;2020-07-29
4. The average relative dose intensity of R‐CHOPis an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients;Cancer Medicine;2019-02-10
5. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study;Gynecologic Oncology;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3